Results 11 to 20 of about 1,057,002 (233)

Minor histocompatibility antigen TCR-T [PDF]

open access: yesBlood Advances
: Minor histocompatibility antigens (MiHA) are polymorphic peptides presented by HLA molecules on recipient cells in allogeneic hematopoietic cell transplantation (allo-HCT) and are derived from proteins with genetic variants that differ between ...
Elizabeth F. Krakow, Marie Bleakley
doaj   +4 more sources

Minor histocompatibility antigens.

open access: yesCurrent Opinion in Immunology, 1997
The existence of transplantation antigens, in addition to those encoded by genes in the MHC, has been known for over half a century. The molecular identification of these additional minor histocompatibility (H) antigens lagged behind that of their MHC
Roopenian, D C, Simpson, E
core   +5 more sources

A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. [PDF]

open access: yesPLoS ONE, 2006
BACKGROUND: Minor Histocompatibility (H) antigen mismatches significantly influence the outcome of HLA-matched allogeneic stem cell transplantation. The molecular identification of human H antigens is increasing rapidly. In parallel, clinical application
Eric Spierings   +6 more
doaj   +3 more sources

The immunogenomics of minor histocompatibility antigens.

open access: yesImmunological Reviews, 2002
Minor histocompatibility (H) antigens are a diverse assemblage of major histocompatibility complex (MHC)-bound peptides with the unifying property of acting as alloantigens that induce allogeneic tissue rejection. They are a consequence of any form of
Derry Roopenian   +5 more
core   +4 more sources

Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. [PDF]

open access: yesPLoS Genetics, 2007
Minor histocompatibility (H) antigens are allogeneic target molecules having significant roles in alloimmune responses after human leukocyte antigen-matched solid organ and stem cell transplantation (SCT).
Eric Spierings   +34 more
doaj   +2 more sources

T-cell receptor repertoires against HLA class I-restricted minor histocompatibility antigens are highly diverse with a small subset of public clonotypes [PDF]

open access: yesJournal for ImmunoTherapy of Cancer
Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) can be a curative treatment for hematological diseases. After HLA-matched alloHSCT, donor T cells may recognize minor histocompatibility antigens (MiHAs), which are polymorphic HLA ...
Marieke Griffioen   +9 more
doaj   +2 more sources

The genetic origin of minor histocompatibility antigens.

open access: yesImmunogenetics, 1993
The purpose of this study was to elucidate the genetic origin of minor histocompatibility (H) antigens. Toward this end common inbred mouse strains, distinct subspecies, and species of the subgenus Mus were examined for expression of various minor H ...
Zuberi, A R   +9 more
core   +4 more sources

CHARACTERIZATION OF MINOR HISTOCOMPATIBILITY ANTIGENS AND THEIR ROLE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE IN TURKIYE

open access: yesSabiad, 2022
Objective: The minor histocompatibility antigens (mHAgs) are the epitopes composed of polymorphic essential peptides, and they create T cell response limited to a variety of class I and II HLA alleles.
Fatma Savran Oğuz   +5 more
doaj   +2 more sources

High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations. [PDF]

open access: yesPLoS ONE, 2011
T-cell recognition of minor histocompatibility antigens (MiHA) plays an important role in the graft-versus-tumor (GVT) effect of allogeneic stem cell transplantation (allo-SCT).
Pleun Hombrink   +7 more
doaj   +2 more sources

Prolonged Skin Graft Survival and Histocompatibility in Highly Inbred Miniature Swine [PDF]

open access: yesTransplantation Direct
Background. Pigs are potential organ donors for humans. Some proposed xenotransplant tolerance regimens require genetically identical cells from different animals (eg, juvenile bone marrow and mature organs or tissues).
Elin Manell, DVM, PhD   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy